Terms ending in 2039
Every in-force patent on Merck Sharp and Dohme LLC's record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,413,352 | Conjugate Based Systems for Controlled Insulin Delivery In force · High confidence | Merck Sharp and Dohme LLC | In force | High confidence | |
| US 11,498,904 | Novel Substituted Biaryl Compounds as Indoleamine 2,3-Dioxygenase (IDO) Inhibitors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 11,111,297 | Antibodies Specific for Immunoglobulin-Like Transcript 3 (ILT3) and Uses Thereof In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 10,713,545 | Image Processing of Webpages In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 12,453,766 | RSV RNA Vaccines In force · High confidence | ModernaTX, Inc. | In force | High confidence | |
| US 12,234,265 | Stabilized RSV F Proteins and Uses Thereof In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 11,377,693 | System and Methods for Deriving Gene Signature Biomarkers of Response to PD-1 Antagonists In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 10,695,928 | Rotary Rod Slicer In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 11,225,471 | Antidiabetic Bicyclic Compounds In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 11,311,528 | Oxo-Tetrahydro-Isoquinoline Carboxylic Acids as Sting Inhibitors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| 47 more term ends in 2039 · Pro | |||||
10 of 57 patents shown. Soonest term end first, then patent number.
Pro members see all 57.
50 of these are in force and held by Merck Sharp and Dohme LLC.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.